# US 2023/0265498 A1 · Nucleic acid sequencing method and apparatus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0265498 A1
- Document ID: US20230265498A1
- Status: Published application
- Kind: A1
- Application number: 18/004,145
- Filed: 2021-07-02
- Published: 2023-08-24
- Earliest claimed: 2020-07-02
- Assignees: Geneus Technologies Co., Ltd.
- Applicants: Geneus Technologies Co., Ltd.
- Inventors: Yaozhong ZOU; Yunpeng SU; Ronghuo QIN; Peng JIANG; Jiazhi LIU
- Web page: https://patentgrep.com/patent/US20230265498A1

## CPC

- C12Q 1/6869: Methods for sequencing
- G01N 27/4473: {by electric means}
- G01N 27/44791: {Microapparatus (sample containers with integrated microfluidic structures B01L3/5027)}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method for determining the type of a nucleotide on a nucleic acid sequence to be analyzed, and a nucleic acid sequencing method. In the method, at least one modified nucleotide for nucleic acid synthesis is separated from a nucleic acid sequence to be analyzed and other components on both sides of a membrane; when the modified nucleotide is transferred to the other side of the membrane under the action of an electric field by means of a nanopore embedded on the membrane, a synthesis reaction is conducted; moreover, the type of a base of the nucleotide is determined according to the change of the electrical properties of the nanopore in the process of the modified nucleotide is transferred by the nanopore, so as to implement sequencing.

## Claims

### Claim 1

A method for determining type of a nucleotide on a nucleic acid sequence to be analyzed, comprising the steps of:
S01 providing at least one nucleotide molecule in a first compartment and a nucleic acid sequence to be analyzed in a second compartment, with the first compartment and the second compartment separated by a membrane having at least one nanopore;
S02 applying an electric field to drive the nucleotide molecule and/or a part thereof to pass through the nanopore in a first direction or to be inserted in the nanopore;
S03 measuring a first current characteristic value passing through the membrane in the state of S02 to identify the nucleotide molecule and/or a part thereof;
S04 applying an electric field in a direction opposite to that of the electric field applied in step S02 or in the same direction but with a lower driving voltage, causing the nucleotide molecule and/or a part thereof to pass through the nanopore and/or exit the nanopore in a second direction, with the second direction being opposite to the first direction;
S05 measuring a second current characteristic value passing through the membrane to identify the nucleotide molecule and/or a part thereof, comparing the second current characteristic value with a pre-determined standard current characteristic value of the nucleotide molecule or polyphosphate molecule in the state of S04 to determine whether the nucleotide molecule and/or a part thereof is attached to the nucleic acid sequence to be analyzed, and thus determining the type of nucleotide on the nucleic acid sequence to be analyzed in the second compartment.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the nucleotide molecule is a modified nucleotide molecule as shown in Formula I.
NXP-L-B Formula I
wherein NXP represents a phosphate deoxyribonucleotide and/or a phosphate nucleotide, the phosphate deoxyribonucleotides comprising dAXP, dTXP, dCXP and dGXP; the phosphate nucleotides comprising AXP, TXP/UXP, CXP and GXP.
L represents a linker part having a long chain segment and a linking segment.
B represents a bulky steric hindrance part, which is a protein molecule, and is connected to the linker part through the linking segment.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the membrane is selected from a natural lipid bilayer or a bilayer membrane formed by artificial amphiphilic molecules.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the nanopore is selected from a natural protein nanopore or a nanopore prepared from artificial material.

### Claim 5 (depends on 1)

The method according to claim 1, wherein a nucleic acid polymerase and a template primer are further provided in the second compartment.

### Claim 6 (depends on 1)

A sequencing method for a nucleic acid sequence to be analyzed, comprising repeating steps S01 to S05 of the method according to claim 1, sequentially determining type of each nucleotide of the nucleic acid sequence to be analyzed until the sequencing of the nucleic acid sequence to be analyzed is completed.

### Claim 7 (depends on 1)

A nucleic acid sequencing device for the method according to claim 1, comprising:
(a) a first compartment and a second compartment separated by a membrane having at least one nanopore;
(b) means for applying an electric field across the membrane; and
(c) components used to measure a current flowing through the membrane.
